Lowering the PSA Threshold for Prostate Biopsy from 4 to 2.5 ng/ml: Influence on Cancer Characteristics and Number of Men Needed to Biopt

Publisher： Karger

E-ISSN： 1423-0399|84|2|141-146

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.84, Iss.2, 2010-03, pp. : 141-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness of Percent Free PSA for Prostate Cancer Detection in Men with a Total PSA of 4–10 ng/ml

By  

Urologia Internationalis, Vol. 79, Iss. 4, 2007-11 ,pp. : 336-344

Karger

Access to resources Recommend Favorite

Patients with Low Prostate-Specific Antigen Levels (≤4 ng/ml) Would Benefit from a Twelve-Core Biopsy Protocol for Prostate Cancer Detection

By  

Urologia Internationalis, Vol. 78, Iss. 4, 2007-05 ,pp. : 318-322

Karger

Access to resources Recommend Favorite

Should Men with Serum Prostate-Specific Antigen ≤4 ng/ml and Normal Digital Rectal Examination Undergo a Prostate Biopsy?

By  

Oncology, Vol. 70, Iss. 2, 2006-05 ,pp. : 81-89

Karger

Access to resources Recommend Favorite

Prevalence and Clinical Significance of Prostate Cancer among 12,682 Men with Normal Digital Rectal Examination, Low PSA Levels (≤4 ng/ml) and Percent Free PSA Cutoff Values of 15 and 20%

By  

Urologia Internationalis, Vol. 78, Iss. 4, 2007-05 ,pp. : 308-312

Karger

Access to resources Recommend Favorite

Is Free/Total PSA Predictive of Pathological Stage and Gleason Score in Patients with Prostate Cancer and Serum PSA ≤10 ng/ml?

By  

Urologia Internationalis, Vol. 76, Iss. 3, 2006-04 ,pp. : 232-235

Karger

Access to resources Recommend Favorite